ARID1A and neoplasm: In addition, as described in Materials and Methods (“patient’s clinical history”), a Q1346* mutation in ARID1A, which is often mutated in clear cell and endometrioid ovarian carcinomas [19], was identified by FoundationOne® CDx testing of tumour tissue.